Literature DB >> 27714853

Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.

Jonathan G Stine1, Curtis K Argo1, Shawn J Pelletier2, Daniel G Maluf2, Patrick G Northup1.   

Abstract

We hypothesize that recipients with pretransplant portal vein thrombosis (PVT) receiving organs from high-risk donors (HRD) are at an increased risk of HAT. Data on all liver transplants in the United States from February 2002 to March 2015 were analyzed. Recipients were sorted into two groups: those with PVT and those without. HRDs were defined by donor risk index (DRI) >1.7. Multivariable logistic regression models were constructed to assess the independent risk factors for HAT with the resultant graft loss ≤90 days from transplantation. A total of 60 404 candidates underwent liver transplantation; of those recipients, 623 (1.0%) had HAT, of which 66.0% (n = 411) received organs from HRDs compared with 49.3% (n = 29 473) in recipients without HAT (P < 0.001); 2250 (3.7%) recipients had pretransplantation PVT and received organs from HRDs. On adjusted multivariable analysis, PVT with a HRD organ was the most significant independent risk factor (OR 3.56, 95% CI 2.52-5.02, P < 0.001) for the development of HAT. Candidates with pretransplant PVT who receive an organ from a HRD are at the highest risk for postoperative HAT independent of other measurable factors. Recipients with pretransplant PVT would benefit from careful donor selection and possibly anticoagulation perioperatively.
© 2016 Steunstichting ESOT.

Entities:  

Keywords:  cirrhosis; coagulopathy; hepatology; outcomes; portal hypertension

Mesh:

Substances:

Year:  2016        PMID: 27714853      PMCID: PMC5154764          DOI: 10.1111/tri.12855

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  47 in total

1.  Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom.

Authors:  Michael A Silva; Periyathambi S Jambulingam; Bridget K Gunson; David Mayer; John A C Buckels; Darius F Mirza; Simon R Bramhall
Journal:  Liver Transpl       Date:  2006-01       Impact factor: 5.799

2.  Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data.

Authors:  R Mateo; Y Cho; G Singh; M Stapfer; J Donovan; J Kahn; T-L Fong; L Sher; N Jabbour; S Aswad; R R Selby; Y Genyk
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

3.  Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donors.

Authors:  Laura C Burlage; Shanice A Karangwa; Ton Lisman; Paulo N A Martins; Robert J Porte
Journal:  Liver Transpl       Date:  2015-07-27       Impact factor: 5.799

4.  Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up.

Authors:  Jang I Moon; Ralph Barbeito; Raquel N Faradji; Jeffrey J Gaynor; Andreas G Tzakis
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

5.  Risk factors associated with early hepatic artery thrombosis after orthotopic liver transplantation - univariable and multivariable analysis.

Authors:  Parveen Warner; Giuseppe Fusai; Georgios K Glantzounis; Caroline A Sabin; Nancy Rolando; David Patch; Dinesh Sharma; Brian R Davidson; Keith Rolles; Andrew K Burroughs
Journal:  Transpl Int       Date:  2011-01-06       Impact factor: 3.782

6.  Hepatic artery thrombosis after liver transplantation and genetic factors: prothrombin G20210A polymorphism.

Authors:  Valeria R Mas; Robert A Fisher; Daniel G Maluf; David S Wilkinson; Carleton T Garrett; Andrea Ferreira-Gonzalez
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

7.  Vascular complications after liver transplantation: a 5-year experience.

Authors:  P Wozney; A B Zajko; K M Bron; S Point; T E Starzl
Journal:  AJR Am J Roentgenol       Date:  1986-10       Impact factor: 3.959

8.  Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases.

Authors:  T Iida; T Kaido; S Yagi; T Hori; Y Uchida; K Jobara; H Tanaka; S Sakamoto; M Kasahara; K Ogawa; Y Ogura; A Mori; S Uemoto
Journal:  Clin Transplant       Date:  2014-07-16       Impact factor: 2.863

9.  Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients.

Authors:  Rosa Ayala; Joaquín Martínez-López; Teresa Cedena; Rosalía Bustelos; Carlos Jimenez; Enrique Moreno; Carmen Ribera
Journal:  BMC Gastroenterol       Date:  2011-11-28       Impact factor: 3.067

10.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16
View more
  7 in total

Review 1.  Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.

Authors:  Jonathan G Stine; Patrick G Northup
Journal:  Dig Dis Sci       Date:  2019-03       Impact factor: 3.199

2.  Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index.

Authors:  Daniel Gaballa; Dmitri Bezinover; Zakiyah Kadry; Elaine Eyster; Ming Wang; Patrick G Northup; Jonathan G Stine
Journal:  Liver Transpl       Date:  2019-09-19       Impact factor: 5.799

Review 3.  Intraoperative Doppler Ultrasound for Detection of Early Postoperative Vascular Complications in Orthotopic Liver Transplants.

Authors:  Raymond I Okeke; Jeffery Bettag; Reeder Wells; Michaela Wycoff; Taylor Hallcox; Justin Lok; Alexandra Phocas; David L Annakie; Ramy Shoela; Mustafa Nazzal
Journal:  Cureus       Date:  2022-06-19

4.  Risk Factors for Transfusion after Orthotopic Liver Transplantation.

Authors:  Ana Paula Hitomi Yokoyama; José Mauro Kutner; Araci Massami Sakashita; Cristiane Yoshie Nakazawa; Tatiana Almeida Omura de Paula; Raffael Perreira Cezar Zamper; Pamella Tung Pedroso; Marcio Dias de Almeida; Sergio Paiva Meira Filho; Fernanda Andrade Orsi
Journal:  Transfus Med Hemother       Date:  2019-04-03       Impact factor: 3.747

5.  Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.

Authors:  Jonathan G Stine; Blake A Niccum; Alex N Zimmet; Nicolas Intagliata; Stephen H Caldwell; Curtis K Argo; Patrick G Northup
Journal:  Clin Transl Gastroenterol       Date:  2018-03-06       Impact factor: 4.488

6.  Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management.

Authors:  Thomas A Verbeek; Jonathan G Stine; Fuat H Saner; Dmitri Bezinover
Journal:  Transplant Direct       Date:  2018-10-26

7.  Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.

Authors:  Steven D Ma; Jennifer Wang; Dmitri Bezinover; Zakiyah Kadry; Patrick G Northup; Jonathan G Stine
Journal:  Res Pract Thromb Haemost       Date:  2019-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.